Institute of Clinical Biochemistry, Hannover Medical School, Hannover, Germany; Centre de Recherche sur les Macromolécules Végétales, Groupe Chimie et Biotechnologie des Oligosaccharides, 601 rue de la Chimie, BP 53X, 38041 Grenoble, Cedex 09, France.
Institute of Clinical Biochemistry, Hannover Medical School, Hannover, Germany.
Carbohydr Polym. 2023 Nov 1;319:121182. doi: 10.1016/j.carbpol.2023.121182. Epub 2023 Jul 8.
Heparosan is an acidic polysaccharide expressed as a capsule polymer by pathogenic and commensal bacteria, e.g. by E. coli K5. As a precursor in the biosynthesis of heparan sulfate and heparin, heparosan has a high biocompatibility and is thus of interest for pharmaceutical applications. However, due to its low immunogenicity, developing antibodies against heparosan and detecting the polymer in biological samples has been challenging. In this study, we exploited the enzyme repertoire of E. coli K5 and the E. coli K5-specific bacteriophage ΦK5B for the controlled synthesis and depolymerization of heparosan. A fluorescently labeled heparosan nonamer was used as a priming acceptor to study the elongation mechanism of the E. coli K5 heparosan polymerases KfiA and KfiC. We could demonstrate that the enzymes act in a distributive manner, producing labeled heparosan of low dispersity. The enzymatically synthesized heparosan was a useful tool to identify the tailspike protein KflB of ΦK5B as heparosan lyase and to characterize its endolytic depolymerization mechanism. Most importantly, using site-directed mutagenesis and rational construct design, we generated an inactive version of KflB for the detection of heparosan in ELISA-based assays, on blots, and on bacterial and mammalian cells.
肝素聚糖是一种酸性多糖,由致病菌和共生菌(如大肠杆菌 K5)作为胶囊聚合物表达。作为肝素硫酸和肝素生物合成的前体,肝素聚糖具有很高的生物相容性,因此引起了药物应用的关注。然而,由于其免疫原性低,开发针对肝素聚糖的抗体并在生物样本中检测该聚合物一直具有挑战性。在这项研究中,我们利用大肠杆菌 K5 的酶谱和大肠杆菌 K5 特异性噬菌体 ΦK5B 来控制肝素聚糖的合成和解聚。我们使用荧光标记的肝素九聚体作为引发接受体来研究大肠杆菌 K5 肝素聚糖聚合酶 KfiA 和 KfiC 的延伸机制。我们能够证明这些酶以分布式方式起作用,产生低分散度的标记肝素聚糖。酶法合成的肝素聚糖是一种有用的工具,可以鉴定 ΦK5B 的尾刺蛋白 KflB 为肝素聚糖裂解酶,并表征其内切解聚机制。最重要的是,我们通过定点突变和合理的构建设计,生成了 KflB 的无活性版本,用于 ELISA 检测试剂盒、印迹分析、细菌和哺乳动物细胞中肝素聚糖的检测。